Warning
IntegraDose Compounding Services LLC Recalls fentaNYL Citrate
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Source: FDA
WarningRecall #D-0548-2026Drug / Pharmaceutical
IntegraDose Compounding Services LLC Recalls fentaNYL Citrate
IntegraDose Compounding Services LLC · Class II — Moderate Risk
Product Description
fentaNYL Citrate, Sterile CADD for Injection, 2,2500 mcg/50mL in Sterile Water, IntegraDose Compounding Services LLC, 3650 Victorie St N, Suite 900, Shoreview, MN, NDC 71139-6030-1.
Reason for Recall
Subpotent Drug
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
Nationwide.
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
The FDA classified this recall as Class II, indicating the pharmaceutical product may cause temporary health problems or poses a slight threat of a serious nature. IntegraDose Compounding Services LLC initiated the recall on May 12, 2026 affecting 376 cassettes. Subpotent Drug. The product was distributed nationwide. Consumers should check their purchases and discontinue use of any affected product. Contact IntegraDose Compounding Services LLC for further instructions.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medication Defects.